The role of branched chain amino acids metabolic disorders in tumorigenesis and progression-Reference-Cited by-同舟云学术

The role of branched chain amino acids metabolic disorders in tumorigenesis and progression

Published:2022-09 Issue: Volume:153 Page:113390
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Wang Jingtong,Wang Wei,Zhu Feng,Duan Qiuhong

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference207 articles.

1. M. Kusaczuk, R. Krętowski, M. Bartoszewicz, M. Cechowska-Pasko Phenylbutyrate-a pan-HDAC inhibitor-suppresses proliferation of glioblastoma LN-229 cell line, Tumour Biol.

2. Sestrins inhibit mTORC1 kinase activation through the GATOR complex;A. N;Cell Rep.,2014

3. Pathogenic homozygous mutations in the DBT gene (c.1174A>C) result in maple syrup urine disease in a rs12021720 carrier;Alijanpour;Lab. Med.,2022

4. From Krebs to clinic: glutamine metabolism to cancer therapy;Altman;Nat. Rev. Cancer,2016

5. Pathophysiology of maple syrup urine disease: Focus on the neurotoxic role of the accumulated branched-chain amino acids and branched-chain alpha-keto acids;Amaral;Neurochem. Int.,2022

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fueling the fight against cancer: Exploring the impact of branched-chain amino acid catalyzation on cancer and cancer immune microenvironment;Metabolism;2024-12

2. Metabolomic biomarkers of multiple myeloma: A systematic review;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

3. Branched-chain amino acids: physico-chemical properties, industrial synthesis and role in signaling, metabolism and energy production;Amino Acids;2024-08-28

4. Design, Synthesis, Antitumor Activity and NMR‐Based Metabolomics of Novel Amino Substituted Tetracyclic Imidazo[4,5‐b]Pyridine Derivatives;ChemMedChem;2024-07-16

5. Cross-talk between BCKDK-mediated phosphorylation and STUB1-dependent ubiquitination degradation of BCAT1 promotes GBM progression;Cancer Letters;2024-06